We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Study: AI Could Save 5-10% in Healthcare Spending

By HospiMedica International staff writers
Posted on 30 Jan 2023
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

A new study by McKinsey & Company (New York City, NY, USA) and Harvard University (Cambridge, MA, USA) estimates that the broader adoption of AI could lead to savings in the range of 5% to 10% in healthcare spending, or between approximately USD 200-360 billion per year in the US.

Presently, the healthcare sector has low adoption of AI-based tools despite its benefits discovered by researchers. The study's estimates are based on AI uses utilizing current technologies that are achievable within the next five years, without compromising quality or access. Hospitals could see cost savings mainly through improved clinical operations, quality and safety – such as optimizing operating rooms, or identifying adverse events. Physician groups can experience similar benefits by leveraging AI for continuity of care, such as referral management.

Health insurers could experience savings from uses that improve claims management, such as automating prior authorization, along with healthcare and provider relationship management, including preventing readmissions and provider directory management. Based on AI-driven uses, private payers could save approximately 7% to 9% of their total costs within the next five years. Physician groups could save 3% to 8% of their costs. Additionally, the report estimates that hospitals could register savings between 4% to 11% in their expenses per year.

Related Links:
McKinsey & Company
Harvard University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Immobilization System
Cranial 4Pi Immobilization
New
Hybrid Arch Device
Neo EDE

Channels

Critical Care

view channel
Image: Protaryx Medical’s Transseptal Puncture Device is a next-generation solution designed to deliver safe, efficient, and reproducible left-atrial entry to support contemporary therapies (photo courtesy of Protaryx Medical)

FDA-Cleared Transseptal Access Device Enables Site-Specific Left Atrial Puncture

Transseptal puncture is essential for gaining left atrial access during structural heart and electrophysiology procedures, yet it can be technically demanding and time-consuming. Suboptimal puncture site... Read more

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more